US Stock MarketDetailed Quotes

DTIL Precision BioSciences

  • 10.3900
  • +0.0100+0.10%
Close Jul 17 16:00 ET
71.96MMarket Cap-1383P/E (TTM)

About Precision BioSciences Company

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's proprietary genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane on January 26, 2006 and is headquartered in Durham, NC.

Company Profile

Company NamePrecision BioSciences
Listing DateMar 28, 2019
Issue Price16.00
CEOMr. Michael Amoroso
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressDibrell Building,302 East Pettigrew Street,Suite A-100
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27701

Company Executives

  • Name
  • Position
  • Salary
  • Michael Amoroso
  • Director, President and Chief Executive Officer
  • 2.04M
  • John Alexander Kelly
  • Chief Financial Officer and Principal Accounting Officer
  • 1.08M
  • Jeff Smith, PhD
  • Chief Research Officer
  • --
  • Dr. Alan List, M.D.
  • Chief Medical Officer
  • 909.97K
  • Kevin J. Buehler
  • Chairman of the Board
  • 188.49K
  • Geno J. Germano
  • Independent Director
  • 169.74K
  • Shari Lisa Pire, J.D.
  • Independent Director
  • 158.90K
  • Melinda Brown
  • Independent Director
  • 158.99K
  • Dr. Stanley R. Frankel, M.D.
  • Independent Director
  • 156.24K
  • Dr. Samuel C. Wadsworth, PhD
  • Independent Director
  • 149.99K
  • Dario Scimeca
  • General Counsel and Secretary
  • --


Analyst Rating

No Data

Price Target

No Data

Heat List
Latest Price